If you had invested $10,000 in three select biotech stocks three years ago, you’d now have nearly $98,000. Which three biotech stocks would have made this accomplishment possible? Celgene (NASDAQ: CELG), Jazz Pharmaceuticals (NASDAQ: JAZZ), and Vertex Pharmaceuticals (NASDAQ: VRTX).
Despite each of these stocks more than tripling in value during the past three years, they’re all still great picks for investors. Here’s why Celgene, Jazz, and Vertex remain top biotech stocks to buy now.